BioNexus Gene Lab Corp Files 2024 10-K
Ticker: BGLC · Form: 10-K · Filed: Apr 15, 2025 · CIK: 1737523
| Field | Detail |
|---|---|
| Company | Bionexus Gene Lab CORP (BGLC) |
| Form Type | 10-K |
| Filed Date | Apr 15, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, financials, medical-laboratories
TL;DR
BioNexus Gene Lab Corp filed its 2024 10-K. Check financials and operations.
AI Summary
BioNexus Gene Lab Corp filed its 2024 10-K on April 15, 2025, reporting on its fiscal year ending December 31, 2024. The company, incorporated in Wyoming, operates in the medical laboratories sector from its Kuala Lumpur address. Key events mentioned include various underwriting agreements and a Cede and Co. transaction in July 2023, alongside provisions for genomic screening services.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of BioNexus Gene Lab Corp's financial performance, operational activities, and risk factors for the fiscal year 2024.
Risk Assessment
Risk Level: medium — The filing details various agreements and provisions, suggesting potential complexities in operations and financial structure that warrant careful review.
Key Numbers
- FY 2024 — Fiscal Year (Period covered by the 10-K filing)
- 2024-12-31 — Fiscal Year End (End date of the reporting period)
- 2025-04-15 — Filing Date (Date the 10-K was submitted to the SEC)
Key Players & Entities
- BioNexus Gene Lab Corp (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-04-15 (date) — Filing date
- Kuala Lumpur (location) — Business and mailing address
- Cede and Co. (company) — Mentioned in relation to a 2023 transaction
FAQ
What were the primary financial results for BioNexus Gene Lab Corp in fiscal year 2024?
The filing is a 10-K for the fiscal year ending December 31, 2024, but specific financial results like revenue or net income are not detailed in the provided header information.
What is the business address of BioNexus Gene Lab Corp?
The business address is 10-2 Tower B, Vertical Business Suite, 8 Jalan Kerinchi, Kuala Lumpur, 59200.
When was BioNexus Gene Lab Corp incorporated or formerly known?
The company was formerly known as BioNexus Gene Lab Coporation, with a name change date of 2018-04-13. Its state of incorporation is Wyoming.
What significant transactions occurred in July 2023 according to the filing?
The filing mentions several underwriting agreements and a Cede and Co. transaction occurring between July 20, 2023, and July 24, 2023.
What is the Standard Industrial Classification (SIC) code for BioNexus Gene Lab Corp?
The SIC code is 8071, which corresponds to SERVICES-MEDICAL LABORATORIES.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on April 15, 2025 regarding BioNexus Gene Lab Corp (BGLC).